Eplontersen for Transthyretin Amyloid Cardiomyopathy.

Fontana M, Masri A, Solomon SD, Cappelli F, Davis MK, García-Pavía P, Gillmore JD, Hanna M, Obici L, Sperry BW, Tahara N, Waddington-Cruz M, Azevedo O, Damy T, de Barros Correia E, Khouri MG, Nikolova AP, Störk S, Conrad T, Yang Q, Claggett BL, Chen J, Brice GT, Tsimikas S, Maurer MS, CARDIO-TTRansform Investigators

Open source

DOI: 10.1056/nejmoa2608510
Published: 2026 Aug 28
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2608510,
  title = {Eplontersen for Transthyretin Amyloid Cardiomyopathy.},
  author = {Fontana M and Masri A and Solomon SD and Cappelli F and Davis MK and García-Pavía P and Gillmore JD and Hanna M and Obici L and Sperry BW and Tahara N and Waddington-Cruz M and Azevedo O and Damy T and de Barros Correia E and Khouri MG and Nikolova AP and Störk S and Conrad T and Yang Q and Claggett BL and Chen J and Brice GT and Tsimikas S and Maurer MS and CARDIO-TTRansform Investigators},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2608510},
  url = {https://doi.org/10.1056/nejmoa2608510}
}

RIS

TY  - JOUR
TI  - Eplontersen for Transthyretin Amyloid Cardiomyopathy.
AU  - Fontana M
AU  - Masri A
AU  - Solomon SD
AU  - Cappelli F
AU  - Davis MK
AU  - García-Pavía P
AU  - Gillmore JD
AU  - Hanna M
AU  - Obici L
AU  - Sperry BW
AU  - Tahara N
AU  - Waddington-Cruz M
AU  - Azevedo O
AU  - Damy T
AU  - de Barros Correia E
AU  - Khouri MG
AU  - Nikolova AP
AU  - Störk S
AU  - Conrad T
AU  - Yang Q
AU  - Claggett BL
AU  - Chen J
AU  - Brice GT
AU  - Tsimikas S
AU  - Maurer MS
AU  - CARDIO-TTRansform Investigators
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2608510
UR  - https://doi.org/10.1056/nejmoa2608510
ER  -

APA

M, F., A, M., SD, S., F, C., MK, D., P, G., JD, G., M, H., L, O., BW, S., N, T., M, W., O, A., T, D., E, D. B. C., MG, K., AP, N., S, S., T, C., Q, Y., BL, C., J, C., GT, B., S, T., MS, M., & Investigators, C. (2026). Eplontersen for Transthyretin Amyloid Cardiomyopathy.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2608510

Source records

pubmed · retrieved 2026-09-27T14:29:49.750Z